Biologics & Biosimilars Market Report

Global and Region Biologics & Biosimilars Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：139
  • REPORT CODE：GMM899038
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Biologics & Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Biologics & Biosimilarsmarket, defines the market attractiveness level of Biologics & Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Biologics & Biosimilars industry, describes the types of Biologics & Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biologics & Biosimilars market and the development prospects and opportunities of Biologics & Biosimilars industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biologics & Biosimilars market in Chapter 13.

    By Player:

    • Teva

    • fizer

    • Gelgen Biopharma

    • Changchun High Tech

    • Roche

    • Biotech Pharma

    • Sanofi

    • Merck

    • Mylan

    • Novo Nordisk

    • 3sbio

    • Johnson & Johnson

    • CP Guojian Pharmacy

    • Lilly

    • Novartis

    • AbbVie

    • Hospira

    • Amgen

    • Sandoz

    By Type:

    • Antibiotic

    • Enzyme

    • Hormone

    • Non-Patented Biological Reagents

    • Other

    By End-User:

    • Tumor

    • Diabetes

    • Cardiovascular

    • Hemophilia

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Biologics & Biosimilars Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Biologics & Biosimilars Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Biologics & Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Biologics & Biosimilars Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Biologics & Biosimilars Market Analysis and Outlook to 2022

    • 7.1 Global Biologics & Biosimilars Consumption (2017-2022)

    • 7.2 United States Biologics & Biosimilars Consumption (2017-2022)

    • 7.3 Europe Biologics & Biosimilars Consumption (2017-2022)

    • 7.4 China Biologics & Biosimilars Consumption (2017-2022)

    • 7.5 Japan Biologics & Biosimilars Consumption (2017-2022)

    • 7.6 India Biologics & Biosimilars Consumption (2017-2022)

    • 7.7 South Korea Biologics & Biosimilars Consumption (2017-2022)

    8 Region and Country-wise Biologics & Biosimilars Market Analysis and Outlook to 2028

    • 8.1 Global Biologics & Biosimilars Consumption Forecast (2022-2028)

    • 8.2 United States Biologics & Biosimilars Consumption Forecast (2022-2028)

    • 8.3 Europe Biologics & Biosimilars Consumption Forecast (2022-2028)

    • 8.4 China Biologics & Biosimilars Consumption Forecast (2022-2028)

    • 8.5 Japan Biologics & Biosimilars Consumption Forecast (2022-2028)

    • 8.6 India Biologics & Biosimilars Consumption Forecast (2022-2028)

    • 8.7 South Korea Biologics & Biosimilars Consumption Forecast (2022-2028)

    9 Global Biologics & Biosimilars Market Outlook by Types and Applications to 2022

    • 9.1 Global Biologics & Biosimilars Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Antibiotic Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Enzyme Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Hormone Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Non-Patented Biological Reagents Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biologics & Biosimilars Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Tumor Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Hemophilia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Biologics & Biosimilars Market Outlook by Types and Applications to 2028

    • 10.1 Global Biologics & Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Antibiotic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Enzyme Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Hormone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Non-Patented Biological Reagents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Biologics & Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Tumor Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Biologics & Biosimilars Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Biologics & Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Biologics & Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Biologics & Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Biologics & Biosimilars Market Competitive Analysis

    • 14.1 Teva

      • 14.1.1 Teva Company Details

      • 14.1.2 Teva Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Teva Biologics & Biosimilars Product and Service

    • 14.2 fizer

      • 14.2.1 fizer Company Details

      • 14.2.2 fizer Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 fizer Biologics & Biosimilars Product and Service

    • 14.3 Gelgen Biopharma

      • 14.3.1 Gelgen Biopharma Company Details

      • 14.3.2 Gelgen Biopharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Gelgen Biopharma Biologics & Biosimilars Product and Service

    • 14.4 Changchun High Tech

      • 14.4.1 Changchun High Tech Company Details

      • 14.4.2 Changchun High Tech Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Changchun High Tech Biologics & Biosimilars Product and Service

    • 14.5 Roche

      • 14.5.1 Roche Company Details

      • 14.5.2 Roche Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Roche Biologics & Biosimilars Product and Service

    • 14.6 Biotech Pharma

      • 14.6.1 Biotech Pharma Company Details

      • 14.6.2 Biotech Pharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Biotech Pharma Biologics & Biosimilars Product and Service

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Details

      • 14.7.2 Sanofi Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Biologics & Biosimilars Product and Service

    • 14.8 Merck

      • 14.8.1 Merck Company Details

      • 14.8.2 Merck Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merck Biologics & Biosimilars Product and Service

    • 14.9 Mylan

      • 14.9.1 Mylan Company Details

      • 14.9.2 Mylan Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Mylan Biologics & Biosimilars Product and Service

    • 14.10 Novo Nordisk

      • 14.10.1 Novo Nordisk Company Details

      • 14.10.2 Novo Nordisk Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novo Nordisk Biologics & Biosimilars Product and Service

    • 14.11 3sbio

      • 14.11.1 3sbio Company Details

      • 14.11.2 3sbio Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 3sbio Biologics & Biosimilars Product and Service

    • 14.12 Johnson & Johnson

      • 14.12.1 Johnson & Johnson Company Details

      • 14.12.2 Johnson & Johnson Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Johnson & Johnson Biologics & Biosimilars Product and Service

    • 14.13 CP Guojian Pharmacy

      • 14.13.1 CP Guojian Pharmacy Company Details

      • 14.13.2 CP Guojian Pharmacy Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 CP Guojian Pharmacy Biologics & Biosimilars Product and Service

    • 14.14 Lilly

      • 14.14.1 Lilly Company Details

      • 14.14.2 Lilly Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Lilly Biologics & Biosimilars Product and Service

    • 14.15 Novartis

      • 14.15.1 Novartis Company Details

      • 14.15.2 Novartis Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Novartis Biologics & Biosimilars Product and Service

    • 14.16 AbbVie

      • 14.16.1 AbbVie Company Details

      • 14.16.2 AbbVie Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 AbbVie Biologics & Biosimilars Product and Service

    • 14.17 Hospira

      • 14.17.1 Hospira Company Details

      • 14.17.2 Hospira Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Hospira Biologics & Biosimilars Product and Service

    • 14.18 Amgen

      • 14.18.1 Amgen Company Details

      • 14.18.2 Amgen Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Amgen Biologics & Biosimilars Product and Service

    • 14.19 Sandoz

      • 14.19.1 Sandoz Company Details

      • 14.19.2 Sandoz Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Sandoz Biologics & Biosimilars Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Biologics & Biosimilars

    • Figure Biologics & Biosimilars Picture

    • Table Global Biologics & Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biologics & Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biologics & Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Biologics & Biosimilars Consumption by Country (2017-2022)

    • Figure United States Biologics & Biosimilars Consumption and Growth Rate (2017-2022)

    • Table Europe Biologics & Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure China Biologics & Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Japan Biologics & Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure India Biologics & Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biologics & Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global Biologics & Biosimilars Consumption Forecast by Country (2022-2028)

    • Figure United States Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibiotic Consumption and Growth Rate (2017-2022)

    • Figure Global Enzyme Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Patented Biological Reagents Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Hemophilia Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Enzyme Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Patented Biological Reagents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Biologics & Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Biologics & Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Biologics & Biosimilars Product and Service

    • Table fizer (Foundation Year, Company Profile and etc.)

    • Table fizer Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table fizer Biologics & Biosimilars Product and Service

    • Table Gelgen Biopharma (Foundation Year, Company Profile and etc.)

    • Table Gelgen Biopharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gelgen Biopharma Biologics & Biosimilars Product and Service

    • Table Changchun High Tech (Foundation Year, Company Profile and etc.)

    • Table Changchun High Tech Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changchun High Tech Biologics & Biosimilars Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Biologics & Biosimilars Product and Service

    • Table Biotech Pharma (Foundation Year, Company Profile and etc.)

    • Table Biotech Pharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotech Pharma Biologics & Biosimilars Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Biologics & Biosimilars Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Biologics & Biosimilars Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Biologics & Biosimilars Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Biologics & Biosimilars Product and Service

    • Table 3sbio (Foundation Year, Company Profile and etc.)

    • Table 3sbio Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3sbio Biologics & Biosimilars Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Biologics & Biosimilars Product and Service

    • Table CP Guojian Pharmacy (Foundation Year, Company Profile and etc.)

    • Table CP Guojian Pharmacy Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table CP Guojian Pharmacy Biologics & Biosimilars Product and Service

    • Table Lilly (Foundation Year, Company Profile and etc.)

    • Table Lilly Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lilly Biologics & Biosimilars Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Biologics & Biosimilars Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Biologics & Biosimilars Product and Service

    • Table Hospira (Foundation Year, Company Profile and etc.)

    • Table Hospira Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hospira Biologics & Biosimilars Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Biologics & Biosimilars Product and Service

    • Table Sandoz (Foundation Year, Company Profile and etc.)

    • Table Sandoz Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Biologics & Biosimilars Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US